Literature DB >> 27393482

Capsule Commentary on Callon et al., Assessing Problematic Substance Use in HIV Care: Which Questions Elicit Accurate Patient Disclosures?

Jeffrey L Jackson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27393482      PMCID： PMC5023614          DOI： 10.1007/s11606-016-3779-y

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  3 in total

1.  Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy.

Authors:  Gregory M Lucas; Michael Griswold; Kelly A Gebo; Jeanne Keruly; Richard E Chaisson; Richard D Moore
Journal:  Am J Epidemiol       Date:  2006-01-04       Impact factor: 4.897

Review 2.  Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy.

Authors:  Geetanjali Chander; Seth Himelhoch; Richard D Moore
Journal:  Drugs       Date:  2006       Impact factor: 9.546

3.  Assessing Problematic Substance Use in HIV Care: Which Questions Elicit Accurate Patient Disclosures?

Authors:  Wynne Callon; Mary Catherine Beach; Somnath Saha; Geetanjali Chander; Ira B Wilson; Michael Barton Laws; Victoria Sharp; Jonathan Cohn; Richard Moore; P Todd Korthuis
Journal:  J Gen Intern Med       Date:  2016-05-19       Impact factor: 5.128
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.